Literature DB >> 12437121

CA-074, but not its methyl ester CA-074Me, is a selective inhibitor of cathepsin B within living cells.

Metwally Montaser1, Gilles Lalmanach, Lukas Mach.   

Abstract

Studies using inhibitors that reportedly discriminate between cathepsin B and related lysosomal cysteine proteinases have implicated the enzyme in a wide range of physiological and pathological processes. The most popular substance to selectively inhibit cathepsin B in vivo is CA-074Me, the methyl ester of the E-64 derivative CA-074. However, we now have found that CA-074Me inactivates both cathepsin B and cathepsin L within murine fibroblasts. In contrast, exposure of these cells to the parental compound CA-074 leads to the selective inhibition of endogenous cathepsin B, while intracellular cathepsin L remains unaffected. These results indicate that CA-074 rather than CA-074Me should be used to specifically inactivate cathepsin B within living cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12437121     DOI: 10.1515/BC.2002.147

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  62 in total

1.  Targeting Cathepsin B for Cancer Therapies.

Authors:  Hang Ruan; Susan Hao; Peter Young; Hongtao Zhang
Journal:  Horiz Cancer Res       Date:  2015 2nd Quarter

2.  Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry.

Authors:  Graham Simmons; Dhaval N Gosalia; Andrew J Rennekamp; Jacqueline D Reeves; Scott L Diamond; Paul Bates
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-04       Impact factor: 11.205

3.  Cathepsin L is involved in proteolytic processing of the Hendra virus fusion protein.

Authors:  Cara Theresia Pager; Rebecca Ellis Dutch
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

4.  Induction of cell death in neuroblastoma by inhibition of cathepsins B and L.

Authors:  Rita Colella; Guizhen Lu; Lisa Glazewski; Bruce Korant; Anjan Matlapudi; Matthew R England; Colin Craft; Christopher N Frantz; Robert W Mason
Journal:  Cancer Lett       Date:  2010-04-01       Impact factor: 8.679

5.  Oxygen-glucose deprivation (OGD) and interleukin-1 (IL-1) differentially modulate cathepsin B/L mediated generation of neuroprotective perlecan LG3 by neurons.

Authors:  Maxim G Saini; Gregory J Bix
Journal:  Brain Res       Date:  2011-12-20       Impact factor: 3.252

6.  Bone microenvironment modulates expression and activity of cathepsin B in prostate cancer.

Authors:  Izabela Podgorski; Bruce E Linebaugh; Mansoureh Sameni; Christopher Jedeszko; Sunita Bhagat; Michael L Cher; Bonnie F Sloane
Journal:  Neoplasia       Date:  2005-03       Impact factor: 5.715

7.  Measurement and Mathematical Characterization of Cell-Level Pharmacokinetics of Antibody-Drug Conjugates: A Case Study with Trastuzumab-vc-MMAE.

Authors:  Aman P Singh; Dhaval K Shah
Journal:  Drug Metab Dispos       Date:  2017-08-18       Impact factor: 3.922

8.  Catch and Release Photosensitizers: Combining Dual-Action Ruthenium Complexes with Protease Inactivation for Targeting Invasive Cancers.

Authors:  Karan Arora; Mackenzie Herroon; Malik H Al-Afyouni; Nicholas P Toupin; Thomas N Rohrabaugh; Lauren M Loftus; Izabela Podgorski; Claudia Turro; Jeremy J Kodanko
Journal:  J Am Chem Soc       Date:  2018-10-22       Impact factor: 15.419

9.  Cystatin C-cathepsin B axis regulates amyloid beta levels and associated neuronal deficits in an animal model of Alzheimer's disease.

Authors:  Binggui Sun; Yungui Zhou; Brian Halabisky; Iris Lo; Seo-Hyun Cho; Sarah Mueller-Steiner; Nino Devidze; Xin Wang; Anders Grubb; Li Gan
Journal:  Neuron       Date:  2008-10-23       Impact factor: 17.173

10.  A major cathepsin B protease from the liver fluke Fasciola hepatica has atypical active site features and a potential role in the digestive tract of newly excysted juvenile parasites.

Authors:  Simone A Beckham; David Piedrafita; Carolyn I Phillips; Nirma Samarawickrema; Ruby H P Law; Peter M Smooker; Noelene S Quinsey; James A Irving; Deanne Greenwood; Steven H L Verhelst; Matthew Bogyo; Boris Turk; Theresa H Coetzer; Lakshmi C Wijeyewickrema; Terry W Spithill; Robert N Pike
Journal:  Int J Biochem Cell Biol       Date:  2009-02-20       Impact factor: 5.085

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.